Boston Partners Portfolio holdings
AUM
$90B
This Quarter Return
+24.24%
1 Year Return
+22.46%
3 Year Return
+79.41%
5 Year Return
+184.54%
10 Year Return
+348.81%
AUM
$64.3B
AUM Growth
+$64.3B
(+17%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
13.59%
Holding
699
New
57
Increased
194
Reduced
350
Closed
81
Top Buys
| 1 |
Boeing
BA
|
$397M |
| 2 |
AbbVie
ABBV
|
$294M |
| 3 |
Allison Transmission
ALSN
|
$276M |
| 4 |
Goldman Sachs
GS
|
$248M |
| 5 |
Amgen
AMGN
|
$219M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$321M |
| 2 |
Merck
MRK
|
$250M |
| 3 |
Kimberly-Clark
KMB
|
$229M |
| 4 |
Pfizer
PFE
|
$219M |
| 5 |
FirstEnergy
FE
|
$209M |
Sector Composition
| 1 | Financials | 21.93% |
| 2 | Healthcare | 15.43% |
| 3 | Industrials | 15.3% |
| 4 | Technology | 13.2% |
| 5 | Consumer Discretionary | 12.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
L3Harris
LHX
$51.2B
| $165M | 0.26% |
872,758
-246,251
| -22% | -$46.5M |
|
127
PACCAR
PCAR
$51.3B
| $164M | 0.26% |
1,903,949
+21,145
| +1% | +$1.82M |
|
128
EnerSys
ENS
$3.75B
| $164M | 0.25% |
1,969,328
-307,697
| -14% | -$25.6M |
|
129
Equity Residential
EQR
$24.5B
| $163M | 0.25% |
2,741,385
+471,900
| +21% | +$28M |
|
130
Ingevity
NGVT
$2.12B
| $162M | 0.25% |
2,137,181
-19,798
| -0.9% | -$1.5M |
|
131
Jazz Pharmaceuticals
JAZZ
$7.96B
| $161M | 0.25% |
977,426
+2,824
| +0.3% | +$466K |
|
132
Helmerich & Payne
HP
$2.03B
| $161M | 0.25% |
+6,939,190
| New | +$161M |
|
|
CHX
133
DELISTED
ChampionX
CHX
| $160M | 0.25% |
10,462,303
-2,122,823
| -17% | -$32.5M |
|
134
Essent Group
ESNT
$6.19B
| $158M | 0.25% |
3,662,119
+369,251
| +11% | +$16M |
|
135
Gentex
GNTX
$6.09B
| $156M | 0.24% |
4,601,552
-42,535
| -0.9% | -$1.44M |
|
136
Travelers Companies
TRV
$61.9B
| $155M | 0.24% |
1,101,569
+12,336
| +1% | +$1.73M |
|
|
AUY
137
DELISTED
Yamana Gold, Inc.
AUY
| $153M | 0.24% |
26,797,460
-15,893,258
| -37% | -$90.8M |
|
|
KSU
138
DELISTED
Kansas City Southern
KSU
| $152M | 0.24% |
745,565
-842,580
| -53% | -$172M |
|
139
Expedia Group
EXPE
$26.2B
| $152M | 0.24% |
1,144,345
+15,565
| +1% | +$2.06M |
|
140
Newmont
NEM
$83.4B
| $151M | 0.24% |
2,529,291
-496,509
| -16% | -$29.7M |
|
141
Canadian Natural Resources
CNQ
$65B
| $151M | 0.24% |
6,293,986
+4,380,039
| +229% | +$105M |
|
142
Reinsurance Group of America
RGA
$12.9B
| $150M | 0.23% |
1,292,452
-1,182,986
| -48% | -$137M |
|
143
Icon
ICLR
$13.9B
| $150M | 0.23% |
768,114
-128,446
| -14% | -$25M |
|
144
Ulta Beauty
ULTA
$23.9B
| $148M | 0.23% |
516,109
+181,684
| +54% | +$52.2M |
|
|
WRK
145
DELISTED
WestRock Company
WRK
| $148M | 0.23% |
+3,399,123
| New | +$148M |
|
146
Evertec
EVTC
$2.21B
| $148M | 0.23% |
3,754,633
-8,064
| -0.2% | -$317K |
|
147
Amdocs
DOX
$9.22B
| $146M | 0.23% |
2,054,358
+254,709
| +14% | +$18.1M |
|
|
148
Merck
MRK
$213B
| $143M | 0.22% |
1,751,669
-3,057,918
| -64% | -$250M |
|
149
Ross Stores
ROST
$49.4B
| $142M | 0.22% |
1,158,413
+218,740
| +23% | +$26.9M |
|
150
Eagle Materials
EXP
$7.22B
| $141M | 0.22% |
1,387,948
+14,696
| +1% | +$1.49M |
|